Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
SS Innovations International ( (SSII) ) has issued an update.
On March 31, 2025, SS Innovations International reported significant achievements for 2024, including the installation of 80 SSi Mantra Surgical Robotic Systems in 75 hospitals and completion of over 3,500 surgeries. The company saw a nearly four-fold increase in revenue to over $22 million and improved gross margins from 12.30% to 36.90%. They anticipate further growth with expected regulatory approvals in the US and Europe by late 2025 or early 2026, and have expanded their intellectual property portfolio and board of directors. The company also made strides in telesurgery, receiving regulatory approval in India and performing 16 telesurgeries, including a robotic cardiac surgery over 2,000km. They continue to enhance their manufacturing and R&D capabilities, with a production capacity of 20 units per month, expandable to 35.
More about SS Innovations International
SS Innovations International, Inc. is a developer of innovative surgical robotic technologies aimed at making robotic surgery affordable and accessible globally. Their primary product, the SSi Mantra surgical robotic system, supports a variety of surgical procedures, including robotic cardiac surgery. Headquartered in India, the company plans to expand its presence with technologically advanced, user-friendly, and cost-effective surgical robotic solutions worldwide.
YTD Price Performance: 18.59%
Average Trading Volume: 1,906
Technical Sentiment Signal: Sell
Current Market Cap: $1.74B
For detailed information about SSII stock, go to TipRanks’ Stock Analysis page.